Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 30, 2015
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2015.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing serves as a notification that a press release containing these details was issued on July 30, 2015, and is attached as Exhibit 99.1.
Material Changes
The filing text does not provide specific data regarding material changes versus prior periods. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Management Commentary
Management Action: The company announced a conference call to be held at 8:30 AM EST on July 30, 2015, to discuss the financial results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is furnished, not "filed," for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section unless expressly incorporated by reference in another filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the periods ended June 30, 2015.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check the transcript or recording of the July 30, 2015, conference call for management commentary on future outlook and risks.
- Confirm whether the furnished information has been incorporated by reference in subsequent filings if relying on it for liability purposes.